Gravitas: India revolutionises Cancer cure research | Russia on cusp of vaccine breakthrough?
WION・2 minutes read
Indian scientists are leading the development of cancer vaccines, alongside Russia, while India has introduced the Cervac HPV vaccine with robust antibody responses. The Serum Institute plans to scale up Cervac production, aligning with the government's vaccination efforts, and Tata Hospital and IIT Mumbai have developed CAR-T technology showing promising results for blood cancer treatment.
Insights
- Indian scientists are leading in the development of cancer vaccines, exemplified by the introduction of Cervac, an HPV vaccine with a potent antibody response against multiple virus strains.
- Collaborative efforts between institutions like Tata Hospital and IIT Mumbai in India have resulted in innovative CAR-T technology for blood cancer treatment, showcasing exceptional effectiveness, reduced pain compared to chemotherapy, and the potential for complete treatment in a single dose.
Get key ideas from YouTube videos. It’s free
Recent questions
What are some advancements in cancer vaccines?
Indian scientists are leading in cancer vaccine development, with Russia also making progress. India has introduced an effective HPV vaccine called Cervac, with a robust antibody response.
Which country is increasing production of Cervac?
The Serum Institute of India plans to increase Cervac production to 70 million doses this year, aligning with government efforts to introduce the vaccine for girls aged 9 to 14.
What technology has Tata Hospital and IIT Mumbai developed?
Tata Hospital and IIT Mumbai have developed CAR-T technology for blood cancer treatment, showing promising results with 99% effectiveness in children and reducing pain compared to chemotherapy.
What is the effectiveness of Cervac against HPV?
Cervac, an HPV vaccine from India, is effective against four strains of the virus, with a robust antibody response nearly 1,000 times higher than baseline.
What are the benefits of CAR-T technology for cancer treatment?
CAR-T technology developed by Tata Hospital and IIT Mumbai offers complete treatment for blood cancer in a single dose, showing 99% effectiveness in children and significantly reducing pain compared to chemotherapy.
Related videos
60 Minutes
Killing cancer with a breakthrough therapy | 60 Minutes Full Episodes
TEDx Talks
A breakthrough in eradicating cancer | Eric Tran | TEDxPortland
The Young Turks
'Our Cancer Drug Is For Rich Westerners, Not Poor Indians'
Surgeoncologist
Self Breast Cancer Detection || Mammography || स्तन कैंसर का खुद से जांच करें - Dr. Ajay Vidyarthi
Vietcetera
Cớ gì yêu thương là sợ hãi? - VJ Thùy Minh | Kháng Thương Ep1
Summary
00:00
Indian Scientists Leading Global Cancer Vaccine Development
- Indian scientists are at the forefront of global efforts to develop cancer vaccines, with Russia also close to creating cancer vaccines and immunomodulatory drugs.
- India has introduced an indigenously made HPV vaccine called Cervac, effective against four strains of the virus, with a robust antibody response nearly 1,000 times higher than baseline.
- The Serum Institute of India plans to significantly increase production of Cervac to 70 million doses this year, aligning with government efforts to introduce the vaccine for girls aged 9 to 14.
- India's Tata Hospital and IIT Mumbai have developed CAR-T technology for blood cancer treatment, with promising results showing 99% effectiveness in children, offering complete treatment in a single dose and significantly reducing pain compared to chemotherapy.
